[Treatment of purulent bronchitis during corticosteroid therapy of pulmonary sarcoidosis. Comparative studies on trimethoprim-sulfamethoxazole and tetracycline].
D000208:Acute Disease; D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001991:Bronchitis / Q000139:chemically induced / Q000150:complications / Q000188:drug therapy*; D004318:Doxycycline / Q000627:therapeutic use; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use*; D012507:Sarcoidosis / Q000150:complications / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000890:Anti-Infective Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D004318:Doxycycline; D011241:Prednisone
Zur Behandlung der eitrigen Bronchitis bei kortikoidbehandlungsbedürftiger Lungensarkoidose. Vergleichende Untersuchungen von Trimethoprim-Sulfamethoxazol und Tetracyclin.